These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22891821)

  • 21. Management of weight gain associated with antipsychotics.
    Birt J
    Ann Clin Psychiatry; 2003 Mar; 15(1):49-58. PubMed ID: 12839432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical implications of weight gain in schizophrenia.
    Kurzthaler I; Fleischhacker WW
    J Clin Psychiatry; 2001; 62 Suppl 7():32-7. PubMed ID: 11346194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Ellinger LK; Ipema HJ; Stachnik JM
    Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials.
    Alvarez-Jiménez M; Hetrick SE; González-Blanch C; Gleeson JF; McGorry PD
    Br J Psychiatry; 2008 Aug; 193(2):101-7. PubMed ID: 18669990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topiramate's effectiveness on weight reduction in overweight/obese persons with schizophrenia: study protocol for a randomized controlled trial.
    Chandradasa M; Champika L; de Silva S; Kuruppuarachchi KALA
    Trials; 2017 Sep; 18(1):435. PubMed ID: 28931411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of weight gain associated with antipsychotic treatment: results from the Canadian National Outcomes Measurement Study in Schizophrenia.
    McIntyre RS; Trakas K; Lin D; Balshaw R; Hwang P; Robinson K; Eggleston A
    Can J Psychiatry; 2003 Nov; 48(10):689-94. PubMed ID: 14674052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
    Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
    J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic association between antipsychotic induced weight gain and FTO gene in a Sri Lankan population.
    de Silva VA; Muneeswaran K; Ratnatunga SS; Ranwala I; Gamage S; Hanwella R; Wijeyaratne CN; Chandrasekharan NV
    Ceylon Med J; 2019 Jun; 64(2):40-45. PubMed ID: 31455065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interventions to reduce weight gain in schizophrenia.
    Faulkner G; Cohn T; Remington G
    Schizophr Bull; 2007 May; 33(3):654-6. PubMed ID: 17449900
    [No Abstract]   [Full Text] [Related]  

  • 30. Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis.
    Siskind DJ; Leung J; Russell AW; Wysoczanski D; Kisely S
    PLoS One; 2016; 11(6):e0156208. PubMed ID: 27304831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication-induced weight gain and dyslipidemia in patients with schizophrenia.
    Fenton WS; Chavez MR
    Am J Psychiatry; 2006 Oct; 163(10):1697-704; quiz 1858-9. PubMed ID: 17012676
    [No Abstract]   [Full Text] [Related]  

  • 32. Weight change and atypical antipsychotic treatment in patients with schizophrenia.
    Jones B; Basson BR; Walker DJ; Crawford AM; Kinon BJ
    J Clin Psychiatry; 2001; 62 Suppl 2():41-4. PubMed ID: 11232752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antipsychotic-induced weight gain--pharmacogenetic studies].
    Olajossy-Hilkesberger L; Godlewska B; Marmurowska-Michałowskal H; Olajossy M; Landowski J
    Psychiatr Pol; 2006; 40(5):1009-20. PubMed ID: 17217242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotic-induced weight gain in patients with schizophrenia.
    Llewellyn DJ; Naughton F
    JAMA; 2008 Apr; 299(16):1898-9; author reply 1899-900. PubMed ID: 18430905
    [No Abstract]   [Full Text] [Related]  

  • 35. The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance.
    Lykkegaard K; Larsen PJ; Vrang N; Bock C; Bock T; Knudsen LB
    Schizophr Res; 2008 Aug; 103(1-3):94-103. PubMed ID: 18579346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of antipsychotic-induced weight gain.
    McIntyre RS; Mancini DA; Basile VS
    J Clin Psychiatry; 2001; 62 Suppl 23():23-9. PubMed ID: 11603882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
    Mukundan A; Faulkner G; Cohn T; Remington G
    Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD006629. PubMed ID: 21154372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schizophrenia, obesity, and antipsychotic medications: what can we do?
    Citrome L; Vreeland B
    Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications.
    Lee AK; Bishop JR
    Pharmacogenomics; 2011 Jul; 12(7):999-1016. PubMed ID: 21787190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
    Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
    J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.